Treatment of Bullous Systemic Lupus Erythematosus
Bullous systemic lupus erythematosus (BSLE) is an autoantibody-mediated vesiculobullous disease in patients with SLE. Autoimmunity in BSLE is characterized by the presence of circulating anti-type VII collagen antibodies. BSLE patients often present with multiple, tense, clear fluid-filled vesicles...
Saved in:
Main Authors: | Lihua Duan, Liying Chen, Shan Zhong, Ying Wang, Yan Huang, Yan He, Jie Chen, Guixiu Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2015/167064 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autoantibody to MDM2: A Potential Serological Marker of Systemic Lupus Erythematosus
by: Yuan Liu, et al.
Published: (2015-01-01) -
Systemic Lupus Erythematosus
by: Chaim Putterman, et al.
Published: (2012-01-01) -
Immunoregulation of NKT Cells in Systemic Lupus Erythematosus
by: Junwei Chen, et al.
Published: (2015-01-01) -
Lupus Enteritis as an Initial Presentation of Systemic Lupus Erythematosus
by: Sisira Sran, et al.
Published: (2014-01-01) -
Endoplasmic Reticulum Stress in Systemic Lupus Erythematosus and Lupus Nephritis: Potential Therapeutic Target
by: Hui-Yuan Li, et al.
Published: (2023-01-01)